Inventor
ZHANG NANJING
US21 patents
⚠️ This page may combine multiple inventors who share the name “ZHANG NANJING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PTC THERAPEUTICS INC
16 patentsUS9879007B2Jan 30, 2018
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC18 citations93
US9617268B2Apr 11, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC32 citations93
US9586955B2Mar 7, 2017
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC22 citations93
US7781478B2Aug 24, 2010
Methods for treating hepatitis C
PTC THERAPEUTICS INC8 citations83
US7772271B2Aug 10, 2010
Methods for treating hepatitis C
PTC THERAPEUTICS INC8 citations83
US12398140B2Aug 26, 2025
Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
PTC THERAPEUTICS INC1 citations62
US11753407B2Sep 12, 2023
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations61
US7973069B2Jul 5, 2011
Methods for treating hepatitis C
PTC THERAPEUTICS INC5 citations61
US12384797B2Aug 12, 2025
Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
PTC THERAPEUTICS INC1 citations60
US11780839B2Oct 10, 2023
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations56
US11685746B2Jun 27, 2023
Heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations51
US10851101B2Dec 1, 2020
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
USRE47689ENov 5, 2019
Compounds for treating spinal muscular atrophy
PTC THERAPEUTICS INC0 citations51
US12139499B2Nov 12, 2024
Heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations49
US11858941B2Jan 2, 2024
Heterocyclic and heteroaryl compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations49
US12577226B2Mar 17, 2026
Compounds for treating Huntington's disease
PTC THERAPEUTICS INC0 citations46